PRTN3 and rheumatoid arthritis: Finally, we investigated whether the interval time since the last rituximab infusion could affect the markers of immunopathogenesis in RA (measured at D4 by the detection of antibodies against citrullinated proteins, ACPA) and thus identify indirectly patients more prone to generate vaccine-elicited antibodies (Figure 1C).